Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer

Phase I/II trial shows promising activity of invikafusp alfa in PD-1–resistant GI cancers

Nivolumab plus ipilimumab improves survival results in MSI-H/dMMR metastatic colorectal cancer

Encorafenib, cetuximab plus chemotherapy yields good response in BRAF V600E mCRC

The hidden biology of addiction and cancer

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer

Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRC

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics

Trastuzumab deruxtecan benefit for some advanced gastric cancers